NovoCure (NVCR) Raw Materials (2014 - 2019)

NovoCure (NVCR) has reported Raw Materials for 6 consecutive years, with $3.4 million the latest figure, recorded in Q2 2019.

• Quarterly Raw Materials rose 36.2% year-over-year to $3.4 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $3.4 million (up 36.2% YoY) and the FY2018 annual result came in at $870000.0, down 79.65% from the prior year.
• Raw Materials climbed to $3.4 million in Q2 2019 per NVCR's latest filing, from $1.5 million in the prior quarter.
• Over the last five years, Raw Materials for NVCR reached as high as $5.9 million in Q3 2017 and fell as low as $870000.0 in Q4 2018.
• A 5-year average of $3.6 million and a median of $3.6 million in 2015 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2015 — Raw Materials jumped 568.82% — and 2018, when it slumped 79.65%.
• Year by year, Raw Materials stood at $3.5 million in 2015, then soared by 49.03% to $5.2 million in 2016, then retreated by 18.44% to $4.3 million in 2017, then sank by 79.65% to $870000.0 in 2018, then soared by 294.37% to $3.4 million in 2019.
• According to Business Quant data, Raw Materials over the past three periods registered $3.4 million, $1.5 million, and $870000.0 for Q2 2019, Q1 2019, and Q4 2018 respectively.